Stay updated with breaking news from Aarons Kelly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WEDNESDAY, June 7, 2023 (HealthDay News) -- For adolescents with obesity, semaglutide is effective for reducing body mass index (BMI) category, according to a study published online May 17 in
Improvement of one or more BMI category seen for majority of participants receiving semaglutide.
A secondary analysis of the STEP TEENS trial, presented at the European Congress on Obesity (ECO 2023) and published in Obesity, demonstrates the
A new secondary analysis of the STEP TEENS trial presented at this year’s European Congress on Obesity (ECO 2023, Dublin 17-20 May) and published in the journal Obesity shows that almost half (45%) of the adolescents assigned to semaglutide in the trial managed to lose enough weight to drop below the clinical cutoff for obesity.
Overall, nearly half dropped below threshold for obesity